Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3133 (MIR3133) is a short, non-coding RNA gene that produces a microRNA molecule, functioning primarily to regulate gene expression post-transcriptionally in humans. MIR3133 is processed from a primary transcript to a pre-microRNA by Drosha and then to a mature microRNA by Dicer; the mature microRNA is incorporated into the RNA-induced silencing complex (RISC), which binds target mRNAs and typically causes their translational inhibition or destabilization. This regulation contributes to cellular processes such as differentiation, proliferation, and development. MIR3133 has been associated with Osteochondrosis and Legg-Calve-Perthes Disease based on gene-disease correlations, but its direct functional role in disease biology or as a therapeutic target is uncharacterized. There is currently minimal publicly available data on the specific biological roles, target genes, or therapeutic relevance of MIR3133; it is best understood as a component of the broader miRNA regulatory network.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3133 (MIR3133).